Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Vasopressin is antidiuretic hormone. It is naturally secreted by the pituitary gland, which acts on the kidneys and blood vessels. Vasopressin is used in the treatment of diabetes insipidus and certain conditions of the stomach after surgery or during abdominal x-rays. It is administered into a muscle or under the skin, or into a vein.

The global vasopressin market is estimated to be valued at US$ 1,112.6 million in 2021 and is expected to exhibit a CAGR of 14.7% over the forecast period (2021-2028).

Figure 1. Global Vasopressin Market Share (%) in Terms of Value, By Region, 2021

Vasopressin  | Coherent Market Insights

Increasing prevalence of autonomic dysreflexia (AD) is expected to drive growth of the global vasopressin market.

According to the National Center for Biotechnology Information (NCBI) 2017, the prevalence of AD in patients with spinal cord injury (SCI) has been reported to range from 20 to 70%, and it is known to occur in over 90% of patients with cervical or upper thoracic SCI.

request-sample

Vasopressin Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,112.6 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 14.7% 2028 Value Projection: US$ 2,912.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Intravenous Injection, Intramuscular Injection, Subcutaneous Injection
  • By Application: Anti-Diuretic Hormone Deficiency, Gastrointestinal Bleeding, Vasodilatory Shock, Ventricular Tachycardia & Fibrillation
  • By End User: Hospital, Clinics, Others
Companies covered:

Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals

Growth Drivers:
  • Increasing prevalence of autonomic dysreflexia (AD)
  • Approval of Vasopressin Drug
Restraints & Challenges:
  • Potential side effects of Vasopressin Drugs

Figure 2. Global Vasopressin Market Share (%), by Type, 2021

Vasopressin  | Coherent Market Insights

The increasing regulatory approvals for vasopressin drug is expected to drive the market growth over the forecast period. For instance, in June 2021, Eagle Pharmaceuticals, Inc., announced that the U.S. Food and Drug and Administration priority review for the company’s abbreviated new drug application for its vasopressin.   

The Eagle Pharmaceuticals, Inc., company’s response to the Complete Response Letter (CRL) was submitted on June 15, 2021. The U.S. FDA assigned a Generic Drug User Fee Amendments/Act GDUFA date of December 15, 2021

Global Vasopressin Market– Impact of Coronavirus (COVID-19) Pandemic-

The recent increasing cases of people suffering from Novel corona virus is expected to sudden increase of cardiac syndrome risk amongst people . This is leading the pharma sector to focus on research and development on advanced vasopressin drugs for treatment purposes. This is expected to boost the growth of the global market in the near future.

Global Vasopressin Market- Restraint

The major factor that is expected to hinder growth of the global vasopressin market include complication resulting from the use vasopressin such as asthma, epilepsy, heart disease, and heart failure.

Key Players

Major players operating in the global vasopressin market include Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals.

Vasopressin is a nonapeptide produced in the hypothalamus, exhibits diverse physiological functions related to hemodynamic modulation, diuresis, and behavior. Vasopressin is similar to oxytocin, differing in the third and eight amino acid.

Vasopressin is indicated for the treatment of postoperative abdominal distention, abdominal roentgenography, Gastrointestinal Bleeding and diabetes insipidus.

Market Dynamics

The increasing approvals of vasopressin drug by regulatory authorities is expected to drive the global vasopressin market growth. For instance, in 2018, Eagle Pharmaceuticals, Inc., received abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration for its vasopressin injection, 1ml. Vasostrict had around US$ 400 million in brand sales in 2017, according to the Eagle Pharmaceuticals, Inc., company financial review.

Key features of the study:

  • This report provides in-depth analysis of the global vasopressin market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global vasopressin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global vasopressin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vasopressin market

Detailed Segmentation:

  • Global Vasopressin Market, By Type:
    • Intravenous Injection
    • Intramuscular Injection
    • Subcutaneous Injection
  • Global Vasopressin Market, By Application:
    • Anti-Diuretic Hormone Deficiency
    • Gastrointestinal Bleeding
    • Vasodilatory Shock
    • Ventricular Tachycardia & Fibrillation
  • Global Vasopressin Market, By End User:
    • Hospital
    • Clinics
    • Others
  • Global Vasopressin Market, By Region:
    • North America
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Par Pharmaceutical*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Novartis AG
    • Ferring Pharmaceuticals
    • Fresenius Kabi Canada
    • Astellas Pharma
    • Shanghai Soho-Yiming Pharmaceuticals
    • Endo International
    • Hybio Pharmaceutical
    • Hainan Zhonghe Pharmaceutical
    • Cumberland Pharmaceuticals

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • New Product Launches
    • Market Trends
    • Brand Analysis
    • Regulatory Scenario
    • PEST Analysis
  4. Global Vasopressin Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact on Overall Market
  5. Global Vasopressin Market, By Type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Intravenous Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Intramuscular Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Subcutaneous Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  6. Global Vasopressin Market, By Application, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Anti-Diuretic Hormone Deficiency
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Gastrointestinal Bleeding
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Vasodilatory Shock
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Ventricular Tachycardia & Fibrillation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  7. Global Vasopressin Market, By End User, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  8. Global Vasopressin Market, By Region, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2028
    • North America
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Region/Country, 2021 – 2028, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Competitive Snapshot
      • Par Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ferring Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi Canada
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Astellas Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shanghai Soho-Yiming Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Endo International
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hybio Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hainan Zhonghe Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cumberland Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 32 figures on "Global Vasopressin Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The global vasopressin market is estimated to be valued at US$ 1,112.6 million in 2021 and is expected to exhibit a CAGR of 14.7% between 2021 and 2028.
Increasing prevalence of autonomic dysreflexia (AD) and approvals of vasopressin drug are expected to drive the market growth over the forecast period.
Hospital segment is expected to hold major market share during the forecast period.
North America is expected to hold largest market share in the market.
Major players operating in the market include Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.